Section Arrow
BBNX.NASDAQ
- Beta Bionics Inc
Quotes are at least 15-min delayed:2026/01/22 03:55 EST
Pre Market
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 16.47
-1.96 (-10.63%)
Day High 
18.43 
Prev. Close
18.43 
1-M High
32.58 
Volume 
1.75M 
Bid
--
Ask
--
Day Low
16.295 
Open
18.43 
1-M Low
16.015 
Market Cap 
811.37M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 22.17 
20-SMA 26.47 
50-SMA 27.93 
52-W High 32.71 
52-W Low 8.89 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.94/--
Enterprise Value
817.10M
Balance Sheet
Book Value Per Share
6.70
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
65.12M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PAVMPAVmed Inc12.05+5.86+94.67%0.08PE
Pre Market -- -- --
LUCDLucid Diagnostics1.13-0.08-6.61%-- 
Pre Market -- -- --
PFSAProfusa Inc0.1146+0.0195+20.50%-- 
Pre Market -- -- --
AVRAnteris Technologies Global Corp6.06+0.31+5.39%-- 
Pre Market -- -- --
BSXBoston Scientific Corp91.71+0.51+0.56%48.9PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed
Business Description
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale ofthe iLet.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.